Detalles de la búsqueda
1.
The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
Nephrol Dial Transplant
; 2024 May 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-38730538
2.
Associations between the EQ-5D-5L and exacerbations of chronic obstructive pulmonary disease in the ETHOS trial.
Qual Life Res
; 33(4): 1029-1039, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38206455
3.
A first step towards best practice recommendations for the design and statistical analyses of pragmatic clinical trials: A modified Delphi approach.
Br J Clin Pharmacol
; 88(12): 5183-5201, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35701368
4.
Relationship between risk, cumulative burden of exacerbations and mortality in patients with COPD: modelling analysis using data from the ETHOS study.
BMC Med Res Methodol
; 22(1): 150, 2022 05 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-35614467
5.
Comparison of Parametric Survival Extrapolation Approaches Incorporating General Population Mortality for Adequate Health Technology Assessment of New Oncology Drugs.
Value Health
; 24(9): 1294-1301, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34452709
6.
Assessing the Influence of Subsequent Immunotherapy on Overall Survival in Patients with Unresectable Stage III Non-Small Cell Lung Cancer from the PACIFIC Study.
Curr Ther Res Clin Exp
; 95: 100640, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34484473
7.
Extrapolating Survival Data Using Historical Trial-Based a Priori Distributions.
Value Health
; 22(9): 1012-1017, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31511177
8.
Structured Benefit-risk assessment: a review of key publications and initiatives on frameworks and methodologies.
Pharm Stat
; 15(4): 324-32, 2016 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-25981683
9.
Improved estimation of overall survival and progression-free survival for state transition modeling.
J Comp Eff Res
; 13(1): e230031, 2024 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38099516
10.
Using 30-day modified rankin scale score to predict 90-day score in patients with intracranial hemorrhage: Derivation and validation of prediction model.
PLoS One
; 19(5): e0303757, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38771834
11.
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study.
J Infect
; 88(4): 106129, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38431156
12.
Progression-free survival with fulvestrant 500 mg and alternative endocrine therapies as second-line treatment for advanced breast cancer: a network meta-analysis with parametric survival models.
Value Health
; 16(2): 403-17, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23538193
13.
Network meta-interpolation: Effect modification adjustment in network meta-analysis using subgroup analyses.
Res Synth Methods
; 14(2): 211-233, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36283960
14.
EXAcerbations of COPD and their OutcomeS on CardioVascular diseases (EXACOS-CV) Programme: protocol of multicountry observational cohort studies.
BMJ Open
; 13(4): e070022, 2023 04 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-37185641
15.
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial.
BMJ Neurol Open
; 5(2): e000478, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37637218
16.
COVID-19 vaccine booster doses provide increased protection against COVID-19 hospitalization compared with previously vaccinated individuals: Interim findings from the REFORCO-Brazil real-world effectiveness study during Delta and Omicron.
Vaccine
; 41(42): 6366-6378, 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37704499
17.
The Role of Expert Opinion in Projecting Long-Term Survival Outcomes Beyond the Horizon of a Clinical Trial.
Adv Ther
; 40(6): 2741-2751, 2023 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071317
18.
Mortality risk reduction with budesonide/glycopyrrolate/formoterol fumarate versus fluticasone furoate/umeclidinium/vilanterol in COPD: a matching-adjusted indirect comparison based on ETHOS and IMPACT.
Curr Med Res Opin
; 39(10): 1395-1405, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37583267
19.
Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review.
J Clin Epidemiol
; 160: 83-99, 2023 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-37380118
20.
Protection against COVID-19 hospitalisation conferred by primary-series vaccination with AZD1222 in non-boosted individuals: first vaccine effectiveness results of the European COVIDRIVE study and meta-regression analysis.
Lancet Reg Health Eur
; 31: 100675, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37547274